Metaview’s founders say: "Amazing companies are still fundamentally relying on shards of memories that people have of these ...

The promoters (Capillary Technologies International Pte Ltd and founder Aneesh Reddy Boddu) collectively hold a dominant ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...

The company is gearing up to launch a suite of in-house developed AI products, which are expected to enhance outsourcing ...

BOSTON, June 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 ...

In an era of rising complexity, rapid technology shifts, budget pressures, and uninsurable risks, traditional security approaches no longer suffice. Businesses need to understand where they're ...

This was the stock's second consecutive day of gains.

Vertex Pharmaceuticals has received a “Moderate Buy” consensus from 29 brokerages, with most analysts either holding or ...

Get the Corporate Services Price Index (CSPI) (YoY) results in real time as they're announced and see the immediate global market impact.

Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.

Jeff Bezos’ space company Blue Origin has added a familiar face to its growing mix of outside lobbyists as the industry faces ...